Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome
- 11 February 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 416 (3) , 279-284
- https://doi.org/10.1016/j.neulet.2007.02.023
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trialActa Neurologica Scandinavica, 2006
- Statin therapy in Alzheimer's diseaseActa Neurologica Scandinavica, 2006
- Lipid metabolism in cognitive decline and dementiaBrain Research Reviews, 2006
- Change in Cognitive Function in Alzheimer’s Disease in African-American and White PersonsNeuroepidemiology, 2005
- Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCKPLoS Medicine, 2005
- Onset of dementia is associated with age at menopause in women with Down's syndromeAnnals of Neurology, 2003
- Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2001
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s DiseaseNeuroepidemiology, 1998
- Onset of dementia is associated with apolipoprotein E ε4 in Down's syndromeAnnals of Neurology, 1996